Am J Transplant, Volume 19, Suppl 3 Archives - Page 156 of 214 - ATC Abstracts

2019 American Transplant Congress
Liver Transplant Outcomes in Patients with Atrial Fibrillation
D. Devuni¹, P. Mahboub², P. Martins², C. Barry¹, I. Zacharias¹, B. Movahedi², G. Barnard¹, A. Bozorgzadeh²
¹Division of Gastroenterology, University of Massachusetts Medical School, Worcester, MA, ²Surgery, Division of Transplantation, University of Massachusetts Medical School, Worcester, MA
*Purpose: There is an increase in percentage of patients over the age of 65 yrs. who are being listed for liver transplantation (LT). Patients with…
2019 American Transplant Congress
Evaluation of an Invasive Fungal Infection Prophylaxis Strategy after Liver Transplantation at a Large Academic Medical Center
M. Jorgenson¹, J. Descourouez¹, D. Felix¹, N. Marka², G. Leverson², J. Smith², L. Fernandez², D. Foley²
¹UW Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Invasive fungal infection (IFI) after liver transplant (LTx) is associated with increased morbidity and mortality. Studies show that IFI prophylaxis improves outcomes but the…
2019 American Transplant Congress
Patterns Of Anti-retroviral Use Among U.s. Liver Transplant Candidates With Hiv
A. A. Shaffer¹, A. G. Thomas², D. L. Segev³
¹Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC, ³Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD
*Purpose: There is a high burden of liver disease among HIV-infected (HIV+) individuals, and the class of antiretroviral therapy (ART) used for their treatment may…
2019 American Transplant Congress
Vaccination And Allosensitization In Solid Organ Transplant Candidates
L. Lourenco¹, K. B. Bain², L. Bowman³, D. C. Brennan⁴, G. A. Ewald⁵, R. R. Hachem⁶
¹Pharmacy, University of Chicago Medicine, Chicago, IL, ²Pharmacy, Barnes-Jewish Hospital, St. Louis, MO, ³Pharmacy, Tampa General Hospital, Tampa, FL, ⁴Internal Medicine, The Johns Hopkins School of Medicine, Baltimore, MD, ⁵Heart Failure and Heart Transplantation, Washington University School of Medicine, St. Louis, MO, ⁶Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO
*Purpose: Clinical practice guidelines recommend vaccinating patients awaiting solid organ transplantation (SOT) against vaccine-preventable infections, but there is little evidence to suggest that vaccination reduces…
2019 American Transplant Congress
Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation
S. Bontha¹, A. Bajwa¹, G. Lorenzo², J. Eason³, D. Maluf⁴, V. Mas⁵
¹Surgery, UTHSC, Memphis, TN, ²Northwestern University, Chicago, IL, ³Director of Transplant Institute UTHSC, Memphis, TN, ⁴UTHSC, Memphis, TN, ⁵Director of Transplant Research Institute, Memphis, TN
*Purpose: Preconditioning of donor kidneys and clinical assessment for need of dialysis early post-transplant vary per each case and are crucial for improving transplant outcomes.…
2019 American Transplant Congress
Long-Term Exposure to Particulate Matter Air Pollution and the Risk of Graft Failure and Mortality in Kidney Transplant Recipients
Y. Kim¹, S. Kwon¹, J. Park², J. Lee³
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Korea, Republic of, ³Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of
*Purpose: Elevated levels of fine particulate matter, 10 μm in aerodynamic diameter (PM10) are associated with increased risk of cardiovascular outcomes and death, but their…
2019 American Transplant Congress
Broadly Profiling the Activation Status of Circulating Immune Cells in Chronic Active Antibody Mediated Rejetion Reveals Increased CD38 and CD16 Expression on Monocytes and NK Cells
K. Sablik, N. Litjens, M. Klepper, M. Betjes
Erasmus MC, Rotterdam, Netherlands
*Purpose: Chronic-active antibody mediated rejection (c-aABMR) contributes significantly to late renal allograft failure. Non-invasive biomarkers of c-aABMR are currently not available but could be valuable…
2019 American Transplant Congress
HuR Dictates HO-1 Expression, Modulates Inflammation and Influences Recipient Outcomes in Liver Transplant Patients
K. J. Dery, K. Nakamura, K. Kadono, H. Hirao, S. Kageyama, T. Ito, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury, an innate-immune dominated hepatocellular damage, is a risk factor of early graft dysfunction and rejection in liver transplantation (LT). HuR, an…
2019 American Transplant Congress
Combined Pre-Transplant Anti-Donor T-Cell Sensitization with Single Nucleotid Polimorphisms (SNPs) for CYP3A4 Tacrolimus Metabolism Identifies Kidney Transplant Patients at High Risk of Allograft Rejection
E. Crespo¹, A. Vidal¹, A. Sefrin², P. Fontova¹, M. Stein², H. Volk², J. Grinyó³, P. Reinke², N. Lloberas¹, O. Bestard³
¹Experimental Nephrology Laboratory, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, ²Nephrology, Charité Campus Virchow-Klinikum, Berlin, Germany, ³Kidney Transplant Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain
*Purpose: Preformed donor-specific (d-sp) T-cell alloimmunity has been associated to high risk of acute rejection (BPAR). Since the individual susceptibility related to specific single nucleotide…
2019 American Transplant Congress
Amiodarone And Primary Graft Dysfunction In Heart Transplantation: Reality Or Myth?
M. Kittleson, J. Patel, D. H. Chang, E. Kransdorf, S. Dimbil, R. Levine, K. Yabuno, L. Czer, M. Hamilton, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Primary graft dysfunction (PGD) after heart transplantation (HTx) is seen in approximately 10-30% of patients immediately post-transplant. The cause of PGD is not clear…